• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Down 2%; Alphabet Posts Upbeat Earnings

    7/24/24 10:17:19 AM ET
    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Specialties
    Health Care
    Get the next $AZTR alert in real time by email

    U.S. stocks traded lower this morning, with the Dow Jones dipping around 400 points on Wednesday.

    Following the market opening Wednesday, the Dow traded down 0.99% to 39,957.30 while the NASDAQ fell 2.08% to 17,622.81. The S&P 500 also fell, dropping, 1.47% to 5,473.80.

    Check This Out: Jim Cramer Calls Axsome A ‘Double Or Nothing Stock,’ Says SAP Is ‘Incredible’

    Leading and Lagging Sectors

    Utilities shares jumped by 0.3% on Wednesday.

    In trading on Wednesday, consumer discretionary shares fell by 2.7%.

    Top Headline

    Alphabet Inc (NASDAQ:GOOG) posted better-than-expected earnings and sales results for its second quarter.

    Alphabet reported second-quarter revenue of $84.742 billion, beating the consensus estimate of $84.202 billion. The tech giant reported quarterly earnings of $1.89 per share, beating analyst estimates of $1.85 per share, according to data from Benzinga Pro.

    Equities Trading UP
                           

    • NuZee, Inc. (NASDAQ:NUZE) shares shot up 230% to $3.37.
    • Shares of Dermata Therapeutics, Inc. (NASDAQ:DRMA) got a boost, surging 202% to $3.93 after falling over 22% on Tuesday.
    • Bone Biologics Corporation (NASDAQ:BBLG) shares were also up, gaining 110% to $2.61.

    Equities Trading DOWN

    • Azitra, Inc. (NYSE:AZTR) shares dropped 75% to $1.23 after the company announced the pricing of a $10 million public offering of 6,665,000 common shares and Class A warrants at $1.50 per share.
    • Shares of Nuwellis, Inc. (NASDAQ:NUWE) were down 42% to $2.3995 after the company announced the pricing of a $2 million public offering of 469,340 common shares at $4.24 a share.
    • Vintage Wine Estates, Inc. (NASDAQ:VWE) was down, falling 33% to $0.0775 after the company announces bankruptcy filing and voluntary delisting and SEC deregistration.

    Also Check This Out: Top 3 Tech And Telecom Stocks That Are Set To Fly In July

    Commodities

    In commodity news, oil traded up 0.9% to $77.66 while gold traded up 0.7% at $2,424.60.

    Silver traded up 0.6% to $29.51 on Wednesday, while copper fell 0.6% to $4.1370.

    Euro zone

    European shares were mostly lower today. The eurozone's STOXX 600 fell 0.3%, Germany's DAX fell 0.8% and France's CAC 40 fell 0.8%. Spain's IBEX 35 Index rose 0.1%, while London's FTSE 100 rose 0.1%.

    The HCOB Eurozone manufacturing PMI declined to 45.6 in July from 45.8 in June, while services PMI slipped to 51.9 from 52.8. The HCOB France composite PMI climbed to 49.5 in July from 48.8 in the prior month, while German composite PMI declined to 48.7 from 50.4.

    The S&P Global Flash UK manufacturing PMI rose to 51.8 in July from 50.9 in June, while services PMI rose to 52.4 in July from 52.1 in the previous month.

    Asia Pacific Markets

    Asian markets closed lower on Wednesday, with Japan's Nikkei 225 falling 1.11%, Hong Kong's Hang Seng Index falling 0.91%, China's Shanghai Composite Index declining 0.46% and India's S&P BSE Sensex declining 0.35%.

    The HSBC India Manufacturing PMI climbed to 58.5 in July from 58.3 the prior month, while services PMI rose to 61.1 in July from 60.5. The au Jibun Bank Flash Japan composite PMI rose to 52.6 in July versus a final reading of 49.7 in June.

    Economics

    • U.S. mortgage applications declined by 2.2% in the latest week, compared to a 3.9% gain in the prior period.
    • The S&P Global flash manufacturing PMI fell to 49.5 in July from 51.6 in June and compared to market estimates of 51.7.
    • The S&P Global composite PMI climbed to 55.0 in July from 54.8 in the prior month.
    • The U.S. trade deficit in goods shrank to $96.84 billion in June versus a $99.37 billion gap in the earlier month.
    • Building permits increased by 3.9% to an annual rate of 1.454 million in June.

    Now Read This: Tesla To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $AZTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZTR
    $BBLG
    $DRMA
    $GOOG

    CompanyDatePrice TargetRatingAnalyst
    Alphabet Inc.
    $GOOGL
    4/20/2026$370.00 → $380.00Overweight
    KeyBanc Capital Markets
    Alphabet Inc.
    $GOOGL
    4/14/2026$390.00 → $405.00Buy
    Citigroup
    Alphabet Inc.
    $GOOGL
    4/10/2026$410.00 → $420.00Outperform
    Mizuho
    Alphabet Inc.
    $GOOGL
    4/10/2026$390.00 → $360.00Outperform
    Wolfe Research
    Alphabet Inc.
    $GOOGL
    3/27/2026$387.00 → $397.00Overweight
    Wells Fargo
    Alphabet Inc.
    $GOOGL
    2/23/2026$387.00Equal Weight → Overweight
    Wells Fargo
    Alphabet Inc.
    $GOOG
    2/5/2026$400.00 → $420.00Buy
    Pivotal Research Group
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Dermata Therapeutics Inc.

    SCHEDULE 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject)

    4/22/26 4:19:45 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Dermata Therapeutics Inc.

    DEFA14A - Dermata Therapeutics, Inc. (0001853816) (Filer)

    4/17/26 5:03:20 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Dermata Therapeutics Inc.

    DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer)

    4/17/26 5:01:27 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Whitfill Travis

    4 - Azitra, Inc. (0001701478) (Issuer)

    4/22/26 5:29:59 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Salva Francisco D.

    4 - Azitra, Inc. (0001701478) (Issuer)

    4/22/26 5:30:00 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Staskey Norm

    4 - Azitra, Inc. (0001701478) (Issuer)

    4/22/26 5:30:01 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Regulatory Affairs Bedoya-Toro Munera Maria E bought $1,270 worth of shares (1,000 units at $1.27), increasing direct ownership by 8,333% to 1,012 units (SEC Form 4)

    4 - Dermata Therapeutics, Inc. (0001853816) (Issuer)

    3/17/26 5:44:21 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Dyt Info Pte. Ltd. bought $400,000 worth of shares (701,754 units at $0.57) (SEC Form 4)

    4 - NuZee, Inc. (0001527613) (Issuer)

    10/16/24 5:10:34 PM ET
    $NUZE
    Other Specialty Stores
    Consumer Discretionary

    Large owner Liu Yumei bought $797,500 worth of shares (542,517 units at $1.47) (SEC Form 4)

    4 - NuZee, Inc. (0001527613) (Issuer)

    7/23/24 5:26:55 PM ET
    $NUZE
    Other Specialty Stores
    Consumer Discretionary

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

    MINNEAPOLIS, April 23, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, announces it will participate in the AATS 106th Annual Meeting taking place May 2–5 in Chicago. The Company will be showcasing its Aquadex SmartFlow® ultrafiltration system for fluid removal at Booth 530. At the start of the event, Nuwellis will attend the ERAS Cardiac Spring Retreat gathering of thought leaders, to discuss best practices and innovation in cardiac surgery care. "AATS is one of the largest congresses in the cardiothoracic arena, and a unique opportunity to showcase our Aquadex technology, and

    4/23/26 8:30:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Announces Aquadex Software Update

    MINNEAPOLIS, April 21, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on solutions for patients with cardiorenal conditions, today announced a software update to its Aquadex SmartFlow® ultrafiltration platform. The update is designed to improve usability, streamline clinical workflow, and enhance overall user experience. A key feature of the release is a more precise ultrafiltration adjustment capability, reducing the step size to 5 mL/hr from 10 mL/hr. This advancement is particularly important in pediatric care, where small-volume fluid shifts can have a significant clinical impact. "The Aquadex software update reflects our commitment to con

    4/21/26 8:30:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Quickplay's Triple Play of New Customers, Products and Partnerships Set to Dominate NAB 2026

    LAS VEGAS, April 19, 2026 /PRNewswire/ -- (2026 NAB Show) - Quickplay, the Content to Value Operating System, today unveiled a broad array of company news including: an AI-enriched solution that identifies social signals and trending topics, and connects them to relevant content within minutes; transformative customer deployments; and powerful industry research and partnerships. Debuting at NAB, Social Signals is a new technology within Quickplay AI Studio that identifies trending cultural moments and matches them with high-value content assets to automatically generate social-r

    4/19/26 10:20:00 AM ET
    $AMZN
    $GOOGL
    $GTN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Computer Software: Programming Data Processing
    Technology

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    KeyBanc Capital Markets reiterated coverage on Alphabet A with a new price target

    KeyBanc Capital Markets reiterated coverage of Alphabet A with a rating of Overweight and set a new price target of $380.00 from $370.00 previously

    4/20/26 9:39:07 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Citigroup reiterated coverage on Alphabet A with a new price target

    Citigroup reiterated coverage of Alphabet A with a rating of Buy and set a new price target of $405.00 from $390.00 previously

    4/14/26 9:24:29 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Mizuho reiterated coverage on Alphabet A with a new price target

    Mizuho reiterated coverage of Alphabet A with a rating of Outperform and set a new price target of $420.00 from $410.00 previously

    4/10/26 8:06:17 AM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

    MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and critical care medicine. He serves as Director of the Center for Acute Care Nephrology, holds the Clark D. West Endowed Chair in Pediatric Nephrology at Cincinnati Children's Hospital Medical Center and is Professor of Pediatrics at the University of Cincinnati College of Medicine. His work has helped define the modern understand

    3/5/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Bone Biologics Corp

    SC 13G/A - Bone Biologics Corp (0001419554) (Subject)

    11/14/24 7:19:34 PM ET
    $BBLG
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Dermata Therapeutics Inc.

    SC 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject)

    11/14/24 5:07:13 PM ET
    $DRMA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Azitra Inc

    SC 13G/A - Azitra, Inc. (0001701478) (Subject)

    11/14/24 12:56:51 PM ET
    $AZTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZTR
    $BBLG
    $DRMA
    $GOOG
    Financials

    Live finance-specific insights

    View All

    Emerging AI-Driven Threats Prompt Renewed Focus on Enterprise Cybersecurity

    Issued on behalf of Quantum Secure Encryption Corp.VANCOUVER, BC, April 10, 2026 /CNW/ -- Equity-Insider.com News Commentary — Anthropic just proved that even the company building the most powerful offensive cyber tool ever created can't keep its own front door locked. A CMS misconfiguration exposed Claude Mythos, a frontier AI model that autonomously finds and exploits zero-day vulnerabilities across every major operating system and browser[1]. The Global X Cybersecurity ETF dropped 4.5% in a single session as Wall Street repriced the entire defensive stack overnight[2]. Anthropic responded with Project Glasswing: restricted Mythos Preview access for 40+ organizations to patch critical infr

    4/10/26 11:30:00 AM ET
    $AVGO
    $ESTC
    $GOOG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software
    Computer Software: Programming Data Processing

    Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

    MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights: Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially.208% increase in U.S. console sales in Q4 versus prior year quarter.Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4.Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter.Closed a $5.0 million private p

    3/10/26 8:15:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

    MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced that it will release financial results for the fourth quarter and full year 2025 on March 10, 2026. Nuwellis will host a conference call and webcast at 9:00 AM ET to discuss its financial results and provide a general business update. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-800-343-4885 (U.S) or 1-203-518-9851 (international) and using the conference ID: N

    2/24/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care